HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

Ogivri

biosimilar to herceptin

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Experts

1.	Miller, Emily M: 1 article (01/2019)
2.	Schwartzberg, Lee S: 1 article (01/2019)

Related Diseases

1.	Neoplasms (Cancer) 01/01/2019 - "Five trastuzumab biosimilars: MYL-1401O (Ogivri), CT-P6 (Herzuma), SB3 (Ontruzant), PF-05280014 (Trazimera), and ABP980 (Kanjinti), have now been approved by the US Food and Drug Administration (FDA) for use in HER2-positive breast cancers. "

Related Drugs and Biologics

1.	Biosimilar Pharmaceuticals
2.	Trastuzumab (Herceptin)
3.	Ontruzant
4.	CT-P6
5.	PF-05280014